Premarin Tablet, Film Coated
Product Images NDC 0046-1101

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Premarin (NDC 0046-1101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Premarin 01)

This appears to be a chart or table with information about the percent of subjects and the percent change from baseline in spine BMD (bone mineral density). Without more context, it is difficult to provide a more detailed description or interpretation.*

FDA Label Image

Figure 2 (Premarin 02)

FDA Label Image

Pfizer-logo (Premarin 03)

This is a description of the distributor of a particular product, which is identified as Wyeth Pharmaceuticals LLC. It is a subsidiary of PizerInc, located in Philadelphia with a zip code of 19101.*

FDA Label Image

Pfizer Logo (Premarin 04)

This text is a statement indicating the distributor of a certain product. The product is distributed by a company named Wyeth Pharmaceuticals LLC. This company is a subsidiary of Pfizer Inc, located in Philadelphia with the zip code 19101.*

FDA Label Image

Principal Display Panel (0.3 MG – LABEL)

Dispense PREMARIN in tight, child-resistant containers at a temperature between 20°C and 25°C (68°F-77°F). Each tablet contains 0.45 mg of naturally occurring conjugated estrogens USP. Accompanying descriptive literature contains the usual dosage. Dispensers must include the Information for NDC 0046-1101-81 Patient leaflet with every prescription dispensed. Further information is available at www.PREMARIN.com. This medication is distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., located in Philadelphia, PA. MADE IN CANADA. This product contains 100 Tablets and it is available for prescription only. LOT/EXP information is not available.*

FDA Label Image

Principal Display Panel (0.3 MG – CARTON)

This is a description for Premarin, a medication that contains conjugated estrogens. The dispenser includes an "Information for the Patient" leaflet with each prescription. The tablets should be stored at 20-25°C (68-77°F) with excursions permitted to 15-30°C (59-86°F). They should be dispensed in tight, child-resistant containers. Each tablet contains 0.625g of conjugated estrogens in their naturally occurring, conjugated form. The usual dosage information can be found in the accompanying descriptive literature. Visit www.PREMARIN.com for more information. The medication is distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc, and made in Canada. The package should be dispensed in child-resistant packaging and is not for household use.*

FDA Label Image

Principal Display Panel (0.3 MG – BLISTER CARD)

This is a description for a medication called Premarin. It is a tablet that contains conjugated estrogens used for hormone replacement therapy. The package contains 1000 tablets and is for prescription use only. The packaging is child-resistant and not intended for household use. There is some unreadable text present in the provided output.*

FDA Label Image

Principal Display Panel (0.3 MG)

FDA Label Image

Principal Display Panel (0.45 MG – LABEL)

Each tablet of PREMARIN contains 1.2 mg of conjugated estrogens in their natural form. Dosage instructions are provided in the accompanying literature. The medication needs to be stored within a temperature range of 20-25°C (68-77°F) and dispensed in child-resistant containers. The package comes with "Information for the Patient" leaflet, and the medication is not for household use. The product is distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. The NDC for the medication is 0046-1104-91, and the code for the lot is not readable.*

FDA Label Image

Principal Display Panel (0.625 MG – LABEL)

This appears to be a label of a medication called PREMARIN. Each tablet contains 1.25 mg of conjugated estrogens. The NDC (National Drug Code) number for this medication is 0046-1104-91, and the packaging includes 1,000 tablets. It is only available with a prescription.*

FDA Label Image

Principal Display Panel (0.625 MG – BOTTLE CARTON)

This is a prescription drug called Premarin, which contains 0.3mg of conjugated estrogens in their naturally occurring forms. It is advised to be stored at 20-25°C (68-77°F) with excursions permitted to 15-30°C (59-86°F). It should be dispensed in child-resistant containers as per USP standards. The recommended dosage for the medicine can be found in the accompanying literature providedby the manufacturer'swebsite. It is manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. based in Philadelphia, PA in the USA. The package includes 1,000 tablets, and should only be used upon a prescription.*

FDA Label Image

Principal Display Panel (0.625 MG)

This is a package of 1,000 tablets of Premarin, which are conjugated estrogens. The tablets are meant for prescription use only and come in a child-resistant container. The package is not intended for household use.*

FDA Label Image

Principal Display Panel (0.625 MG)

The text is a description of the medication PREMARIN in the form of 0.3 mg conjugated estrogen tablets, which are available in blister cards containing five tablets. The dosage instructions indicate that one tablet per day is typical, and the packaging should be kept in a cool, dry place. There is also a notation regarding the origin and identification of the medicine.*

FDA Label Image

Principal Display Panel (0.625 MG -CARTON)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.